Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism ZBTB11 inhibitors(zinc finger and BTB domain containing 11 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Preclinical | United States | 21 May 2024 |